05/17/2024
8:03 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:04 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:05 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:06 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:07 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:28 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/05/2024
3:25 PM | Dyne Therapeutics (Filer)
| Form ARS | |
04/05/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:20 PM | Dyne Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
8:06 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
8:07 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 3/A | |
04/04/2024
6:04 PM | Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
04/04/2024
3:22 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
3:24 PM | Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Cox John (Reporting)
Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:39 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:56 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:57 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:58 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:42 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:56 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:56 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:57 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:45 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:50 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:52 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:35 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:35 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:36 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:32 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:33 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:34 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:51 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:53 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:53 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:54 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:17 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:17 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
03/07/2024
7:18 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:18 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:19 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:16 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
4:07 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:22 AM | Dyne Therapeutics (Filer)
| Form S-3ASR | |
03/05/2024
6:35 AM | Dyne Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
6:40 AM | Dyne Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
6:41 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
8:33 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
8:33 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
8:33 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
8:37 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
8:37 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
8:38 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:11 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
6:49 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
6:52 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
6:53 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
6:13 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:15 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:30 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
4:22 PM | Atlas Venture Fund XI, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:42 PM | Atlas Venture Fund XI, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
5:58 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
5:59 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:23 PM | Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
4:14 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
4:14 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
4:15 PM | Atlas Venture Fund XI, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
5:35 PM | Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:36 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:29 PM | Atlas Venture Fund XI, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:39 AM | Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
4:40 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:26 PM | Dyne Therapeutics (Subject)
| Form SC 13G | |
01/26/2024
6:46 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024
6:47 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024
6:47 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
6:48 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
6:49 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:38 PM | Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G | |
01/19/2024
8:08 AM | Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
01/11/2024
3:31 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:07 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
01/05/2024
7:02 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
8:48 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:49 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Overlooked Retirement Asset You Probably Don’t Own (Ad) 4 out of 5 Americans believe we’re on the brink of a retirement crisis.
Luckily, in these unprecedented times, we have an unprecedented solution.
Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. |
01/04/2024
8:45 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
8:45 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
8:46 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
8:46 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:47 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:19 PM | Dyne Therapeutics (Filer)
| Form S-3MEF | |
01/04/2024
4:12 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:12 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024
7:13 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
